Even The Royals Listen Now: Business Wars | The Race to Ozempic
Nov 24, 2025
Dive into the high-stakes battle over Ozempic, the hottest weight-loss drug on the market. The podcast uncovers a raid exposing a black market of counterfeit vials that could jeopardize health. Discover the dangers of dodgy online knockoffs and the race between major players like Novo Nordisk and Eli Lilly in a multi-billion dollar industry. Learn how regulatory bodies are trying to combat these fakes. It's a thrilling exploration of business warfare, where consumer safety hangs in the balance.
AI Snips
Chapters
Transcript
Episode notes
Celebrity Hype Drives Dangerous Demand Surge
- Ozempic's rapid celebrity-driven popularity caused demand to explode across America.
- Supply shortages opened space for dangerous, unregulated alternatives to proliferate online.
Cincinnati Raid Reveals Fake Ozempic Shipments
- David Brown describes an August 2025 raid where agents seized thousands of vials labeled semaglutide in Cincinnati.
- The episode uses this raid to illustrate widespread illegal shipments and fake Ozempic flooding the U.S. market.
Counterfeits Threaten Safety And Brand Value
- Counterfeit semaglutide vials threaten both patient safety and the original drug's reputation.
- Novo Nordisk and regulators see knockoffs as a dual problem of public health and brand/profit erosion.